Details of the Drug

General Information of Drug (ID: DM0SECE)

Drug Name

Synthetic survivin peptide vaccine

Indication

Disease Entry	ICD 11	Status	REF
Glioblastoma	2A00	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Vaccine

Cross-matching ID

References

1	ClinicalTrials.gov (NCT05163080) Prospective Randomized Placebo-Controlled Trial of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE). U.S.National Institutes of Health.